Aspirin: Cancer-Fighting Wonder Drug?
Aspirin has been touted as a potential heart helper, and Tuesday, the British medical journal The Lancet released some evidence that the humble analgesic might also reduce the risk of dying from various forms of cancer, and by an impressive percentage in some cases.
Aspirin has been touted as a potential heart helper, and Tuesday, the British medical journal The Lancet released some evidence that the humble analgesic might also reduce the risk of dying from various forms of cancer, and by an impressive percentage in some cases.
Gizmodo helpfully broke it down for those who don’t want to read the Lancet study:
Rooted in Truth.Gizmodo:
• After 5 years of daily aspirin, death due to gastrointestinal cancers decreased by 54% • After 20 years, death due to prostate cancer decreased by 10% • After 20 years, death due to lung cancer decreased by 30% (among those with adenocarcinomas, typically seen in nonsmokers) • After 20 years, death due to colorectal cancer decreased by 40% • After 20 years, death due to esophageal cancer decreased by 60%
Independent by Design.
Your support helps ensure that rigorous reporting, thoughtful analysis, and investigative journalism remain accessible to everyone.
Support independent journalism.
Environment
For decades, communities have relied on the agency's cancer risk estimates to hold polluters accountable. This year, it's missing.
Health & Wellness
A new analysis suggests the EPA’s limits are too high to prevent nitrate-related cancer, thyroid disease and birth defects.
Health & Wellness
Scientists say chemicals in everything from food packaging to bath products cause lasting health damage and call for urgent global action.
Editorial Cartoons
Editorial Cartoons
Visit Ann Telnaes’ Substack Open Windows for more.
Health & Wellness
Frequent exposure to plastic chemicals — especially through food packaging — makes potential impacts more concerning, say researchers.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.